• 1
    Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673682.
  • 2
    Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J & Dixit VM (1997) The receptor for the cytotoxic ligand TRAIL. Science 276, 111113.
  • 3
    Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI et al. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818821.
  • 4
    Suliman A, Lam A, Datta R & Srivastava RK (2001) Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20, 21222133.
  • 5
    Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM & Jeremias I (2003) TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB. Oncogene 22, 38423852.
  • 6
    Franco AV, Zhang XD, Van Berkel E, Sanders JE, Zhang XY, Thomas WD, Nguyen T & Hersey P (2001) The role of NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J Immunol 166, 53375345.
  • 7
    Tang W, Wang W, Zhang Y, Liu S, Liu Y & Zheng D (2009) Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor κB. FEBS J 276, 581593.
  • 8
    Shetty S, Gladden JB, Henson ES, Hu X, Villanueva J, Haney N & Gibson SB (2002) Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFκB activation in epithelial derived cell lines. Apoptosis 7, 413420.
  • 9
    Tang W, Wang W, Zhang Y, Liu S, Liu Y & Zheng D (2009) TRAIL receptor mediates inflammatory cytokine release in an NF-κB-dependent manner. Cell Res 19, 758767.
  • 10
    Helbig G, Christopherson KW II, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE & Nakshatri H (2003) NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278, 2163121638.
  • 11
    Busillo JM & Benovic JL (2007) Regulation of CXCR4 signaling. Biochim Biophys Acta 1768, 952963.
  • 12
    Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH, Ren L, Wong D, Korz W, Merzouk A et al. (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25, 201211.
  • 13
    Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, Petrucci E, Biffoni M, Nuzzolo ER, Billi M, Foa R et al. (2008) A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 10, 788801.
  • 14
    Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J & Benz CC (2008) Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27, 56435647.
  • 15
    Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS & Welch DR (2009) Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69, 12791283.
  • 16
    Taganov KD, Boldin MP, Chang KJ & Baltimore D (2006) NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103, 1248112486.
  • 17
    Burger JA & Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 17611767.
  • 18
    Ehtesham M, Winston JA, Kabos P & Thompson RC (2006) CXCR4 expression mediates glioma cell invasiveness. Oncogene 25, 28012806.
  • 19
    Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V & Macino G (2010) An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115, 265273.
  • 20
    Zhang XD, Zhang XY, Gray CP, Nguyen T & Hersey P (2001) Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Cancer Res 61, 73397348.
  • 21
    Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L & Shim H (2005) Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65, 967971.
  • 22
    Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 5056.
  • 23
    Rose DP, Connolly JM & Liu XH (1994) Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res 54, 65576562.
  • 24
    Schaller G, Fuchs I, Pritze W, Ebert A, Herbst H, Pantel K, Weitzel H & Lengyel E (1996) Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. Clin Cancer Res 2, 18791885.
  • 25
    Chen CZ (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353, 17681771.
  • 26
    Kumar MS, Lu J, Mercer KL, Golub TR & Jacks T (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39, 673677.
  • 27
    Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM & Condorelli G (2008) MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27, 38453855.
  • 28
    Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P et al. (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16, 498509.
  • 29
    Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C, Iaboni M, Nuovo G, Croce CM & Condorelli G (2010) miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res 70, 36383646.
  • 30
    Ovcharenko D, Kelnar K, Johnson C, Leng N & Brown D (2007) Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67, 1078210788.
  • 31
    Garofalo M, Condorelli GL, Croce CM & Condorelli G (2010) MicroRNAs as regulators of death receptors signaling. Cell Death Differ 17, 200208.
  • 32
    Hu WH, Johnson H & Shu HB (1999) Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways. J Biol Chem 274, 3060330610.
  • 33
    Sanlioglu AD, Dirice E, Aydin C, Erin N, Koksoy S & Sanlioglu S (2005) Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells. BMC Cancer 5, 54.
  • 34
    Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S & Liu ZG (2000) The death domain kinase RIP is essential for TRAIL (Apo2 L)-induced activation of IκB kinase and c-Jun N-terminal kinase. Mol Cell Biol 20, 66386645.
  • 35
    Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D & Ashkenazi A (2005) Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 280, 4059940608.
  • 36
    Rhee JW, Lee KW, Sohn WJ, Lee Y, Jeon OH, Kwon HJ & Kim DS (2007) Regulation of matrix metalloproteinase-9 gene expression and cell migration by NF-κB in response to CpG-oligodeoxynucleotides in RAW 264.7 cells. Mol Immunol 44, 13931400.
  • 37
    Wei W, Wang D, Shi J, Xiang Y, Zhang Y, Liu S, Liu Y & Zheng D (2010) Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway. Mol Immunol 47, 24752484.
  • 38
    Livak KJ & Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the inline image. Methods 25, 402408.